Your browser doesn't support javascript.
loading
Discriminatory performance of insulin-like growth factor 1 and insulin-like growth factor binding protein-3 by correlating values to chronological age, bone age, and pubertal status for diagnosis of isolated growth hormone deficiency.
Choi, Yu Jung; Lee, Yoon Ji; Lee, Na Yeong; Lee, Seon-Hwa; Kim, Seul-Ki; Ahn, Moon-Bae; Kim, Shin-Hee; Cho, Won-Kyoung; Cho, Kyoung-Soon; Jung, Min Ho; Suh, Byung-Kyu.
Afiliação
  • Choi YJ; Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Lee YJ; Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Lee NY; Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Lee SH; Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Kim SK; Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Ahn MB; Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Kim SH; Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Cho WK; Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Cho KS; Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Jung MH; Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Suh BK; Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Ann Pediatr Endocrinol Metab ; 25(4): 240-247, 2020 Dec.
Article em En | MEDLINE | ID: mdl-32871649
PURPOSE: The discriminatory performance of insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) was investigated by correlating their values with chronological age (CA), bone age (BA), and pubertal status (PS) for diagnosis of isolated growth hormone deficiency (IGHD). METHODS: We evaluated IGF-1 and IGFBP-3 levels in 310 short-stature subjects subdivided into 2 groups: IGHD (n=31) and non-IGHD (n=279). IGF-1 and IGFBP-3 were assayed using immune-radiometric assay and transformed into standard deviation score (SDS) according to CA, BA, and PS. RESULTS: The highest sensitivity was found in IGF-1-SDS for CA and IGFBP-3-SDS for CA (22.6% and 30.0%, respectively). The highest specificity was found in IGF-1-SDS for PS and IGFBP-3-SDS for PS (98.2% and 94.4%, respectively). Groups with the highest positive predictive values were IGF-1-SDS for BA and IGFBP-3-SDS for BA (10.9% and 5.1%, respectively). Highest negative predictive values were seen in IGF-1-SDS for CA and IGFBP-3-SDS for CA (98.4% and 98.4%, respectively). CONCLUSION: IGF-1-SDS for CA, instead of IGF-1-SDS for BA or PS, could be used as a standard variable for IGHD screening. The sufficiently high specificity of IGF-1-SDS for PS suggests that this value is a useful tool for identification of IGHD.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article